Expertise

Board certified pathologist, Consultant at the Department of Pathology of Rigshospitalet at the University of Copenhagen. Main diagnostic and research area since 2005 has been thoracic pathology and molecular pathology. ESR has published 86 peer-reviewed manuscripts and co-authored 26 book-chapters. He has lectured widely nationally and internationally on thoracic diseases and has staged over 50 oral presentations on pathology and molecular pathology at international meetings.

Primære forskningsområder

Diagnostic and predictive biomarkers for malignant pleura mesothelioma and lung cancer;

Molecular pathology of human cancers;

Thoracic diseases.

Aktuel forskning

Identifying and validating novel diagnostic and predictive biomarkers for malignant pleural mesothelioma and lung cancer using the expression profiles of genes, microRNAs and proteins.

ESR is member of the: International Mesothelioma Interest Group; Advisory Board for Malignant Pleural Mesothelioma of the Danish National Board of Health; Committee for the Danish Cancer Research Foundation; Scientific Board for the Danish Association for Cancer Research; American Association for Cancer Research; European Association for Cancer Research; European Society of Pathology; Thymus & Mediastinum Interest Group; Nordic Thoracic Oncology Group.

Has supervised 8 PhD-students, 4 master students and 4 research assistants. Chairman for 1 PhD defence in Denmark; Opponent for 6 PhD defences in Denmark, Italy, and Norway.

Since 1994, peer reviewer of articles for more than 40 different international journals related to cancer research, pathology and molecular pathology.

Mulige interessekonflikter

During the last 10 years ESR has received honoraria for lectures and expert board-activities from Pfizer, Roche, Novartis, Abbott, and Ely Lilli and one research grant from Pfizer and one from Roche.